Actavia Life Sciences Inc

NEW
OTCPK:RASP (USA)  
$ 0.00050 -0.0035 (-87.5%) 10:08 PM EST
At Loss
Market Cap:
$ 386.00K
Enterprise V:
$ 688.00K
Volume:
0
Avg Vol (2M):
0
Trade In:
Volume:
0
At Loss
Avg Vol (2M):
0

Business Description

Actavia Life Sciences Inc
NAICS : 325412 SIC : 2834
ISIN : US7538881068
Description
Actavia Life Sciences Inc is a clinical-stage biotechnology company focused on targeted drugs to treat diseases in oncology and immunology, mainly focusing on the treatment of leukemia. Its primary indication is Acute Myeloid Leukemia (AML), which may be fatal within weeks to months, has about a 5-year survival rate of only about 25% and very poor prospects for the long-term survival of patients.

Financial Strength

Name Current Vs Industry Vs History

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
6-1 Month Momentum %
-87.5
12-1 Month Momentum %
-87.5

Liquidity Ratio

Name Current Vs Industry Vs History

Dividend & Buy Back

Name Current Vs Industry Vs History

Profitability Rank

Name Current Vs Industry Vs History

GF Value Rank

Name Current Vs Industry Vs History

GF Valueâ„¢

Actavia Life Sciences Inc Filings

Filing Date Document Date Form
No Filing Data

Actavia Life Sciences Inc Stock Events

Financials Calendars
Event Date Price ($)
3.25:1 Stock Split 2016-09-20 0.46 (+0.00%)
Show
Entries

Guru Commentaries on OTCPK:RASP

No articles.

Press Release

Subject Date
No Press Release

Articles on Actavia Life Sciences Inc

No articles.

Headlines

See More
  • 1
No news.
  • 1